THERAPIES
-
Hemophilia B gene therapy approved by U.S. FDA
Montreal – November 28, 2022 – The U.S. Food and Drug Administration (FDA) approved the first gene therapy for hemophilia B on November 22. Etranacogene...
-
No change to factor IX product mix in Quebec
Montreal, August 15, 2022 – On July 15, Héma-Québec announced the results of the recombinant factor IX tender for the period from October 1, 2022...
-
The FactorFirst card has been revised
The highly popular and useful FactorFirst card has been revised and the new version is now available for orders! Thank you to a great team...
-
Hearing the patient voice on therapy choice: FVIII or non-FVIII
by the Canadian Association of Nurses in Hemophilia Care – Ontario Region* and Sarah Crymble, Ontario Hemophilia Provincial Coordinator Treatment for patients with hemophilia A...
-
Memorial art – helping to prevent future calamity … helping to heal
by Rick Waines, British Columbia In 1983 I was 17 and attended my first WFH meeting in Stockholm, Sweden, and at the opening plenary Dr....